News
The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...
Here’s how COVID-19 vaccine guidance is changing in the U.S. For people at high risk of severe COVID-19. The process of ...
Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...
The upcoming changes raise questions for people who may still want a fall COVID-19 shot but don’t clearly fit into one of the ...
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
WASHINGTON — The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with ...
The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...
The new framework will also seek for vaccine makers to conduct a randomized controlled trial before the agency signs off on a coronavirus shot for healthy people between the ages of 6 months and ...
The agency said it would approve new versions of the vaccine only for adults 65 years of age and older as well as for people with one or more risk factors for severe COVID-19 outcomes. These risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results